Literature DB >> 11702114

Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET.

C Y Wong1, R Nuñez, P Bohdiewicz, R J Welsh, G W Chmielewski, K P Ravikrishnan, J C Hill, S E Pursel, D Fink-Bennett, H Balon, C Dickinson, H J Dworkin.   

Abstract

The aim of this study was to identify useful patterns of abnormal fluorine-18 fluorodeoxyglucose (FDG) uptake by different types of non-small cell (NSC) lung cancer and to assess their clinical implications. One hundred and three sequential patients with newly diagnosed, pathology-proven NSC lung cancer were included. FDG positron emission tomography (PET) images were acquired using a dedicated PET scanner. There were 35 squamous cell carcinomas (SQC), 17 large cell cancers (LGC), 38 adenocarcinomas (ADC), 1 bronchioloalveolar carcinoma (BAC) and 12 non-classified NSC cancers. PET images were categorized into detectable patterns of necrotic center in the primary tumor, satellite lesions (T4), hilar lymph nodes (N1), and N2, N3, and M1 lesions by visual interpretation of PET images for SQC, LGC, and ADC (n=90; BAC and non-classified NSC cancers were excluded). The PET lesions were correlated with surgical pathology and with CT findings in inoperable cases. Necrosis was more commonly present in the primary tumors of LGC (53%) and SQC (43%) than in those of ADC (26%) (P<0.0001 and <0.01, respectively). The frequencies of nodal uptake in ADC, SQC and LGC were similar (71%, 60%, and 59%, respectively). However, M1 lesions were present significantly more often in LGC (41%) and ADC (34%) than in SQC (3%) (both P<0.0001). Significantly more surgically inoperable cases were found by PET (T4, N3, M1) in ADC (50%) and LGC (41%) than in SQC (26%) (P<0.001 and <0.02, respectively). Our results suggest a wide variation of PET findings for different types of NSC lung cancer. Identification of these patterns is useful in clinical PET interpretation, in that knowledge of the most probable association between the PET patterns and the histological types will facilitate initial staging and planning of management.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702114     DOI: 10.1007/s002590100638

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Sestamibi scintigraphy reveals adenocarcinoma of the lung.

Authors:  J Malamitsi; S Papadopoulos; K Iliadis; M Pagou; L Lamprakos; K Dalianis; R Efthimiadou; J Andreou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

2.  Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma.

Authors:  S H Kim; K-N Lee; E J Kang; D W Kim; S H Hong
Journal:  Br J Radiol       Date:  2011-02-08       Impact factor: 3.039

3.  Bronchogenic squamous cell carcinoma mass with central photopenia on FDG-PET scan.

Authors:  Vikram Sahni; Sebnem Guvenc-Tuncturk; Harman S Paintal; Ware G Kuschner
Journal:  Clin Med Res       Date:  2011-08-04

4.  Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.

Authors:  Benjamin Houdu; Charline Lasnon; Idlir Licaj; Guy Thomas; Pascal Do; Anne-Valerie Guizard; Cédric Desmonts; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-14       Impact factor: 9.236

5.  Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters.

Authors:  Sun-pyo Hong; Seung Eun Lee; Yoon-La Choi; Sung Wook Seo; Ki-Sun Sung; Hong Hoe Koo; Joon Young Choi
Journal:  Skeletal Radiol       Date:  2014-02-15       Impact factor: 2.199

6.  The rim sign: FDG-PET/CT pattern of pulmonary infarction.

Authors:  Michael Soussan; Edmond Rust; Gabriel Pop; Jean-François Morère; Pierre-Yves Brillet; Véronique Eder
Journal:  Insights Imaging       Date:  2012-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.